Komori
General Meetings of Shareholders4512WAKAMOTO PHARMACEUTICAL CO.,LTD.Pharmaceuticals

(Correction) Notice of Convocation for the 2025 Annual General Meeting of Shareholders

On page 18 of the business report in the notice of convocation for the 2025 Annual General Meeting of Shareholders, the stated gain on the sale of investment securities was corrected from ¥491 million to ¥419 million.

Worth reading
43Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
72000000
¥
Wording
Definitive
How definitive the wording is.

The document this correction applies to

Timely disclosure
Notice of Convocation of the 2025 Annual General Meeting of Shareholders2025-05-24

What was corrected and how

A subsequent correction by the company to the contents of an already published filing.

Original disclosure2025年5月24日

Notice of Convocation of the 130th Annual General Meeting of Shareholders

Open the original document
4 daysThe pre-correction wording stayed published for this period (Calculated from the Original Disclosure Date Indicated in the Document)
This correction2025-05-28
Location of correction (where in the original document)

第130回定時株主総会招集ご通知18ページ 事業報告(2024年4月1日から2025年3月31日まで) 1 会社の現況 (1)事業の状況 ①事業の経過及び成果

Before correction

4億9千1百万円

After correction

4億1千9百万円

Changes△7千2百万円
Reason for correction

招集ご通知の校了手続き完了後に確認されたことから

What was corrected and how
ItemDetails
Disclosure subject to correctionNotice of Convocation of the 130th Annual General Meeting of Shareholders
Original disclosure date2025年5月24日
Location of correction第130回定時株主総会招集ご通知18ページ 事業報告(2024年4月1日から2025年3月31日まで) 1 会社の現況 (1)事業の状況 ①事業の経過及び成果
Details of correction4億9千1百万円 → 4億1千9百万円
Reason for correction招集ご通知の校了手続き完了後に確認されたことから
Items this document does not state (1)
Impact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

招集ご通知の校了手続き完了後に、訂正すべき事項が確認されたため。

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
(Correction) Notice of Convocation for the 2025 Annual General Meeting of Shareholders | WAKAMOTO PHARMACEUTICAL CO.,LTD. (4512) timely disclosure | Komori